MPG.eBooks - Description: Ketamine for treatment-resistant depression or post-traumatic stress disorder in various settings

Cover Image

Read Now

Ketamine for treatment-resistant depression or post-traumatic stress disorder in various settings a review of clinical effectiveness, safety, and guidelines

To inform clinical practice on the treatment of patients with TRD or PTSD, this report aimed to provide evidence on the clinical benefits and harms and evidence-based guidelines on the off-label use of ketamine in various settings

Bibliographic Details
Main Authors:	Kim, Joanne, Mierzwinski-Urban, Monika (Author)
Corporate Author:	Canadian Agency for Drugs and Technologies in Health
Format:	eBook
Language:	English
Published:	Ottawa (ON) Canadian Agency for Drugs and Technologies in Health 2017, March 1, 2017
Series:	Rapid response report: summary with critical appraisal
Subjects:	Ketamine / Therapeutic Use Stress Disorders, Post-traumatic / Drug Therapy Off-label Use Treatment Outcome Depressive Disorder, Treatment-resistant / Drug Therapy
Online Access:	https://www.ncbi.nlm.nih.gov/books/NBK487457
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa

Description
Summary:	To inform clinical practice on the treatment of patients with TRD or PTSD, this report aimed to provide evidence on the clinical benefits and harms and evidence-based guidelines on the off-label use of ketamine in various settings
Physical Description:	1 PDF file (30 pages) illustrations